Herein, the high biocompatibility and hemocompatibility properties of the HSA-modified NPs are reported along with the very strong increase in signal stability and the efficient and specific uptake by a cancer cell line via a SPARC-mediated mechanism. The gene discussed is ALB; the disease is cancer.